|
1
|
Wang Y and Jiang T: Understanding high
grade glioma: Molecular mechanism, therapy and comprehensive
management. Cancer Lett. 331:139–146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
van den Bent M, Chinot OL and Cairncross
JG: Recent developments in the molecular characterization and
treatment of oligodendroglial tumors. Neuro Oncol. 5:128–138. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kalpathy-Cramer J, Gerstner ER, Emblem KE,
Andronesi OC and Rosen B: Advanced magnetic resonance imaging of
the physical processes in human glioblastoma. Cancer Res.
74:4622–4637. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Van Schaeybroeck S, Allen WL, Turkington
RC and Johnston PG: Implementing prognostic and predictive
biomarkers in CRC clinical trials. Nat Rev Clin Oncol. 8:222–232.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Reis-Filho JS and Pusztai L: Gene
expression profiling in breast cancer: Classification,
prognostication, and prediction. Lancet. 378:1812–1823. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hayden MS and Ghosh S: NF-κB, the first
quarter-century: Remarkable progress and outstanding questions.
Genes Dev. 26:203–234. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Perkins ND: The diverse and complex roles
of NF-κB subunits in cancer. Nat Rev Cancer. 12:121–132. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
DiDonato JA, Mercurio F and Karin M: NF-κB
and the link between inflammation and cancer. Immunol Rev.
246:379–400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cha ST, Tan CT, Chang CC, Chu CY, Lee WJ,
Lin BZ, Lin MT and Kuo ML: Retraction: G9a/RelB regulates
self-renewal and function of colon-cancer-initiating cells by
silencing Let-7b and activating the K-RAS/β-catenin pathway. Nat
Cell Biol. 19:762016. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kitamura T, Kometani K, Hashida H,
Matsunaga A, Miyoshi H, Hosogi H, Aoki M, Oshima M, Hattori M,
Takabayashi A, et al: SMAD4-deficient intestinal tumors recruit
CCR1+ myeloid cells that promote invasion. Nat Genet. 39:467–475.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kenagy RD, Hart CE, Stetler-Stevenson WG
and Clowes AW: Primate smooth muscle cell migration from aortic
explants is mediated by endogenous platelet-derived growth factor
and basic fibroblast growth factor acting through matrix
metalloproteinases 2 and 9. Circulation. 96:3555–3560. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ge QL, Liu SH, Ai ZH, Tao MF, Ma L, Wen
SY, Dai M, Liu F, Liu HS, Jiang RZ, et al: RelB/NF-κB links cell
cycle transition and apoptosis to endometrioid adenocarcinoma
tumorigenesis. Cell Death Dis. 7:e24022016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sau A, Lau R, Cabrita MA, Nolan E, Crooks
PA, Visvader JE and Pratt MA: Persistent activation of NF-κB in
BRCA1-deficient mammary progenitors drives aberrant proliferation
and accumulation of DNA damage. Cell Stem Cell. 19:52–65. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gardella KA, Muro I, Fang G, Sarkar K,
Mendez O and Wright CW: Aryl hydrocarbon receptor nuclear
translocator (ARNT) isoforms control lymphoid cancer cell
proliferation through differentially regulating tumor suppressor
p53 activity. Oncotarget. 7:10710–10722. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hänzelmann S, Castelo R and Guinney J:
GSVA: Gene set variation analysis for microarray and RNA-seq data.
BMC Bioinformatics. 14:72013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng H, Takahashi H, Murai Y, Cui Z,
Nomoto K, Niwa H, Tsuneyama K and Takano Y: Expressions of MMP-2,
MMP-9 and VEGF are closely linked to growth, invasion, metastasis
and angiogenesis of gastric carcinoma. Anticancer Res.
26:3579–3583. 2006.PubMed/NCBI
|
|
17
|
Deryugina EI and Quigley JP: Tumor
angiogenesis: MMP-mediated induction of intravasation- and
metastasis-sustaining neovasculature. Matrix Biol 44–46. 1–112.
2015.
|
|
18
|
Gao M, Zhang X, Li D, He P, Tian W and
Zeng B: Expression analysis and clinical significance of eIF4E,
VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma.
Oncotarget. 7:85502–85514. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo F, Tänzer S, Busslinger M and Weih F:
Lack of nuclear factor-kappa B2/p100 causes a RelB-dependent block
in early B lymphopoiesis. Blood. 112:551–559. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bellet MM, Zocchi L and Sassone-Corsi P:
The RelB subunit of NFκB acts as a negative regulator of circadian
gene expression. Cell Cycle. 11:3304–3311. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McMillan DH, Baglole CJ, Thatcher TH,
Maggirwar S, Sime PJ and Phipps RP: Lung-targeted overexpression of
the NF-κB member RelB inhibits cigarette smoke-induced
inflammation. Am J Pathol. 179:125–133. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu Y, Josson S, Fang F, Oberley TD, St
Clair DK, Wan XS, Sun Y, Bakthavatchalu V, Muthuswamy A and St
Clair WH: RelB enhances prostate cancer growth: Implications for
the role of the nuclear factor-kappaB alternative pathway in
tumorigenicity. Cancer Res. 69:3267–3271. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu L, Zhu B, Yang L, Zhao X, Jiang H and
Ma F: RelB regulates Bcl-xl expression and the irradiation-induced
apoptosis of murine prostate cancer cells. Biomed Rep. 2:354–358.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mineva ND, Wang X, Yang S, Ying H, Xiao
ZX, Holick MF and Sonenshein GE: Inhibition of RelB by
1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer
cells to radiation. J Cell Physiol. 220:593–599. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu J, Zhou P, Sun A and Guo F: Effect of
nuclear transcription factor RelB on the proteasome
inhibitor-sensitivity of chronic lymphocytic leukemia cells.
Zhonghua Xue Ye Xue Za Zhi. 35:524–527. 2014.(In Chinese).
PubMed/NCBI
|
|
26
|
Roskelley CD, Srebrow A and Bissell MJ: A
hierarchy of ECM-mediated signalling regulates tissue-specific gene
expression. Curr Opin Cell Biol. 7:736–747. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Park HI, Ni J, Gerkema FE, Liu D,
Belozerov VE and Sang QX: Identification and characterization of
human endometase (Matrix metalloproteinase-26) from endometrial
tumor. J Biol Chem. 275:20540–20544. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shah FD, Shukla SN, Shah PM, Shukla HK and
Patel PS: Clinical significance of matrix metalloproteinase 2 and 9
in breast cancer. Indian J Cancer. 46:194–202. 2009. View Article : Google Scholar : PubMed/NCBI
|
